Compare, Analyse Dr. Reddys with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs TEVA PHARMA (Israel) - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 DR. REDDYS LAB   TEVA PHARMA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
TEVA PHARMA
Dec-13
DR. REDDYS LAB/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,3633,123-   
Low Rs2,3522,713-   
Sales per share (Unadj.) Rs1,054.21,792.3-  
Earnings per share (Unadj.) Rs121.9112.0-  
Cash flow per share (Unadj.) Rs190.2256.8-  
Dividends per share (Unadj.) Rs25.0098.01-  
Dividend yield (eoy) %0.93.4 26.0%  
Book value per share (Unadj.) Rs938.71,990.9-  
Shares outstanding (eoy) m166.17848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.71.6 166.5%   
Avg P/E ratio x23.426.1 89.9%  
P/CF ratio (eoy) x15.011.4 132.2%  
Price / Book Value ratio x3.01.5 207.7%  
Dividend payout %20.587.5 23.4%   
Avg Mkt Cap Rs m474,8312,474,447 19.2%   
No. of employees `00021.744.9 48.2%   
Total wages/salary Rs m33,8020-   
Avg. sales/employee Rs Th8,091.033,816.7 23.9%   
Avg. wages/employee Rs Th1,561.30-   
Avg. net profit/employee Rs Th935.82,112.5 44.3%   
INCOME DATA
Net Sales Rs m175,1701,519,893 11.5%  
Other income Rs m6,2060-   
Total revenues Rs m181,3761,519,893 11.9%   
Gross profit Rs m24,421416,224 5.9%  
Depreciation Rs m11,348122,854 9.2%   
Interest Rs m98329,853 3.3%   
Profit before tax Rs m18,296263,516 6.9%   
Minority Interest Rs m01,197 0.0%   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m0-172,984 0.0%   
Tax Rs m-1,403-3,217 43.6%   
Profit after tax Rs m20,26094,947 21.3%  
Gross profit margin %13.927.4 50.9%  
Effective tax rate %-7.7-1.2 628.1%   
Net profit margin %11.66.2 185.1%  
BALANCE SHEET DATA
Current assets Rs m125,9911,026,530 12.3%   
Current liabilities Rs m72,141895,221 8.1%   
Net working cap to sales %30.78.6 355.8%  
Current ratio x1.71.1 152.3%  
Inventory Days Days7391 80.5%  
Debtors Days Days10596 109.2%  
Net fixed assets Rs m83,854496,431 16.9%   
Share capital Rs m8313,741 22.2%   
"Free" reserves Rs m155,1570-   
Net worth Rs m155,9881,688,313 9.2%   
Long term debt Rs m1,304777,155 0.2%   
Total assets Rs m232,2533,473,444 6.7%  
Interest coverage x19.69.8 199.6%   
Debt to equity ratio x00.5 1.8%  
Sales to assets ratio x0.80.4 172.4%   
Return on assets %9.13.6 254.6%  
Return on equity %13.05.6 231.0%  
Return on capital %12.64.9 255.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m44,5770-   
CASH FLOW
From Operations Rs m29,841242,192 12.3%  
From Investments Rs m-4,923-85,819 5.7%  
From Financial Activity Rs m-25,159-290,526 8.7%  
Net Cashflow Rs m-266-134,152 0.2%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.82 Rs / USD

Compare DR. REDDYS LAB With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare DR. REDDYS LAB With: TORRENT PHARMA  ORCHID PHARMA  J.B.CHEMICALS  SHASUN PHARMA  WYETH  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

DR. REDDYS LAB SHARE PRICE


Apr 16, 2021 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. REDDYS LAB

DR. REDDYS LAB 5-YR ANALYSIS

COMPARE DR. REDDYS LAB WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS